menu_open Columnists
Kewal Handa

Kewal Handa

The Economic Times

We use cookies to provide some features and experiences in QOSHE

More information  .  Close

India’s drug pricing policy must balance affordability, medicine availability and pharma industry growth

Due to the technical or legal reasons, readability mode is not available for this article. Thank you for your kind understanding.

30.10.2026 40

The Economic Times

Kewal Handa